Yousif Capital Management LLC trimmed its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 2.9% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 80,877 shares of the real estate investment trust’s stock after selling 2,396 shares during the period. Yousif Capital Management LLC’s holdings in Sabra Healthcare REIT were worth $1,413,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank purchased a new position in Sabra Healthcare REIT during the fourth quarter worth about $48,950,000. Northern Trust Corp raised its holdings in Sabra Healthcare REIT by 27.7% during the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust’s stock worth $72,214,000 after purchasing an additional 905,466 shares in the last quarter. Thrivent Financial for Lutherans raised its holdings in Sabra Healthcare REIT by 95.9% during the fourth quarter. Thrivent Financial for Lutherans now owns 1,816,217 shares of the real estate investment trust’s stock worth $31,457,000 after purchasing an additional 888,908 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Sabra Healthcare REIT during the fourth quarter worth about $14,241,000. Finally, Wellington Management Group LLP raised its holdings in Sabra Healthcare REIT by 33.7% during the fourth quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust’s stock worth $55,511,000 after purchasing an additional 808,207 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
SBRA has been the subject of several analyst reports. Scotiabank increased their price target on shares of Sabra Healthcare REIT from $18.00 to $19.00 and gave the stock a “sector perform” rating in a report on Monday, May 12th. Truist Financial upped their target price on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.50.
Insider Activity
In other news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the sale, the director now directly owns 64,725 shares in the company, valued at $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.10% of the company’s stock.
Sabra Healthcare REIT Trading Up 1.3%
Shares of SBRA opened at $18.14 on Wednesday. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.89. The firm’s 50-day moving average is $17.72 and its two-hundred day moving average is $17.27. Sabra Healthcare REIT, Inc. has a twelve month low of $14.30 and a twelve month high of $20.03. The firm has a market capitalization of $4.32 billion, a P/E ratio of 30.75, a PEG ratio of 1.36 and a beta of 0.85.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last released its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, beating the consensus estimate of $0.36 by $0.01. The business had revenue of $183.54 million for the quarter, compared to analyst estimates of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The company’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.35 earnings per share. On average, research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 annualized dividend and a dividend yield of 6.62%. Sabra Healthcare REIT’s dividend payout ratio is presently 203.39%.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
- Five stocks we like better than Sabra Healthcare REIT
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- How to Choose Top Rated Stocks
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.